From: COVID-19 pandemic crisis—a complete outline of SARS-CoV-2
Study title | Conditions | Interventions | Locations |
---|---|---|---|
Evaluation of Ganovo (danoprevir) combined with ritonavir in the treatment of SARS-CoV-2 infection | COVID-19 | Drug: Ganovo + ritonavir/interferon nebulization | • The Ninth Hospital of Nanchang, Nanchang, Jiangxi, China |
The use of tocilizumab in the management of patients who have severe COVID-19 with suspected pulmonary hyper inflammation | COVID-19 pneumonia | Drug: tocilizumab | • Hadassah Medical Orginisation, Jerusalem, Israel • Barzilai Medical Center, Ashkelon, Israel • Wolfson Medical Center, Holon, Israel • Sheba Medical Center, Ramat Gan, Israel |
Fluoxetine to reduce intubation and death after COVID19 infection | COVID-19 cytokine storm | Drug: fluoxetine | University of Toledo, Toledo, OH, USA |
Hydroxychloroquine and zinc with either azithromycin or doxycycline for treatment of COVID-19 in outpatient setting | COVID-19 | Drug: hydroxychloroquine, azithromycin, zinc sulfate, doxycycline | St Francis Hospital, Roslyn, NY, USA |
Favipiravir in hospitalized COVID-19 patients | COVID-19 | Drug: favipiravir, hydroxychloroquine | Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran |
Azithromycin in hospitalized COVID-19 patients | COVID-19 | Drug: hydroxychloroquine, azithromycin | Shahid Modarres Hospital, Shahid Beheshti University of Medical Sciences and Health Services, Tehran, Iran, Islamic Republic of |
Prophylaxis of exposed COVID-19 individuals with mild symptoms using chloroquine compounds | • SARS-CoV2 • Symptomatic condition • COVID-19 | • Drug: hydroxychloroquine sulfate regular dose, hydroxychloroquine sulfate loading dose, chloroquine, placebo | • Expo COVID Isolation Center/Mayo Hospital Field Hospital, Lahore, Punjab, Pakistan • Mayo Hospital/King Edward Medical University, Lahore, Punjab, Pakistan • Pakistan Kidney and Liver Institute, Lahore, Punjab, Pakistan |
BCG vaccine for health care workers as defense against COVID 19 | • Coronavirus • Coronavirus infection • Coronavirus as the cause of diseases classified elsewhere | • Biological: BCG vaccine • Biological: placebo vaccine | • Cedars-Sinai Medical Center, Los Angeles, CA, USA • Harvard T.H. Chan School of Public Health, Boston, MA, USA • Texas A&M Family Care Clinic, Bryan, TX, USA and 4 more |
Hydroxychloroquine in patients with newly diagnosed COVID-19 compared to standard of care | • COVID-19 • Coronavirus Infection • SARS-CoV-2 • 2019-nCoV • 2019 novel coronavirus | • Drug: hydroxychloroquine • Dietary supplement: vitamin C | Portland Providence Medical Center, Portland, OR, USA |
Efficacy of dexamethasone treatment for patients with ARDS caused by COVID-19 | Acute respiratory distress syndrome caused by COVID-19 | • Drug: dexamethasone | • ICU, Hospital Universitari Mutua Terrassa, Terrassa, Barcelona, Spain • Hospital Universitario Dr. Negrin, Las Palmas de Gran Canaria, Las Palmas, Spain • Department of Anesthesia, Hospital Universitario de Cruces, Barakaldo, Vizcaya, Spain and 21 more |